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ABSTRACT
The deposition of proteins onto newly spliced mRNAs has far reaching consequences for their subsequent metabolism.
We affinity-purified spliced human mRNPs under physiological conditions from HeLa nuclear extract and present the first
comprehensive inventory of their protein composition as determined by mass spectrometry. Several proteins previously not
known to be mRNP-associated were detected, including the DEAD-box helicases DDX3, DDX5, and DDX9, and the ELG,
hNHN1, BCLAF1, and TRAP150 proteins. The association of some of the newly identified mRNP proteins was shown to be
splicing-dependent, but not to require EJC formation. Initial recruitment of EJC proteins to the spliceosome did not require an
EJC binding platform at the 20/24 region of the 59 exon. Finally, while recruitment of EJC proteins and stable EJC formation
were not dependent on the cap binding complex, several of the newly identified mRNP proteins required the latter for their
association with mRNPs. These results provide novel insights into the composition of spliced mRNPs and the requirements for
the association of mRNP proteins with the newly spliced mRNA.
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INTRODUCTION
Splicing is a fundamental step in eukaryotic gene expression
during which introns are excised from pre-mRNA and exons
are ligated together to form a continuous reading frame
(for review, see Will and Lu¨hrmann 2006). The mRNA
product generated by splicing is complexed with a currently
unknown number of proteins, some of which are deposited
as a consequence of splicing. These proteins influence every
aspect of the subsequent metabolism of the mRNA, in-
cluding its export from the nucleus, translation efficiency,
and stability in the cytoplasm (for review, see Moore 2005).
In this way, splicing not only plays a crucial role in the
maturation of an mRNA in the nucleus, but also has far
reaching downstream effects on the ultimate fate of mRNAs
in the cell.
Splicing is catalyzed by the spliceosome, which forms by
the ordered association of the U1, U2, U4/U6, and U5
spliceosomal snRNPs and numerous non-snRNP proteins
with the pre-mRNA (for review, see Will and Lu¨hrmann
2006). Distinct spliceosome assembly/functional intermedi-
ates can be isolated including the E, A, B, B*, and C
complexes (forming in that order). Upon catalytic activa-
tion, the B complex (which contains all of the above-
mentioned snRNPs), is converted to the activated B*
complex, which lacks the U1 and U4 snRNPs. Complex
C is formed after the first catalytic step of splicing and, after
the second step, the spliced mRNA, in the form of an
mRNP, and the excised intron (initially complexed with the
U2, U5, and U6 snRNPs) are released.
Mass spectrometry (MS) analyses provided a comprehen-
sive inventory of the protein composition of the A, B, B*,
and C spliceosomal complexes (Hartmuth et al. 2002;
Jurica et al. 2002; Makarov et al. 2002; Deckert et al.
2006). They also revealed that a large number of proteins
associate with the pre-mRNA, many in a highly dynamic
manner. Our understanding of the protein composition of
spliced mRNPs, in contrast, is far from complete. Initially,
immunoprecipitation studies provided valuable informa-
tion about proteins associated with mRNAs in cell extracts
(for review, see Dreyfuss et al. 2002). More recently,
affinity-selected mRNPs generated by in vitro splicing were
subjected to MS and their protein composition identified.
However, the latter mRNPs were isolated in the presence of
heparin, which strips off all but the most tightly associated
proteins (Reichert et al. 2002; Tange et al. 2005).
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The best characterized group of proteins known to bind
mRNAs are those of the exon junction complex (EJC),
which in mammals binds in a sequence-independent man-
ner to spliced mRNAs 20–24 nucleotides (nt) upstream of
the site of exon–exon ligation (Le Hir et al. 2000; Tange et al.
2005; for review, see Tange et al. 2004). The EJC is a highly
dynamic entity, consisting of several core proteins that stably
associate with the mRNA, as well as other factors that bind
in a weaker or transient manner. Core components of the
human EJC include the proteins Y14 and Magoh, which
form a tight heterodimer (Lau et al. 2003), as well as eIF4A3/
DDX48 and MLN51/BTZ, which appear to be the only EJC
components directly contacting the mRNA (Ballut et al.
2005; Tange et al. 2005; Stroupe et al. 2006). A stable EJC
core RNP complex can be reconstituted in vitro from the
latter four proteins in the presence of single-stranded RNA
and ATP. Like the EJC generated by splicing, formation of
this complex leads to the protection of an 8–9 nucleotide
stretch of the mRNA from nucleolytic digestion (Ballut et al.
2005). Less stably associated or transiently associated EJC
components include Aly/REF (also termed BEF and
THOC4), UAP56/DDX39, TAP/NXF1, RNPS1, Pinin, Acinus,
SAP18, SRm160, hUpf1, hUpf2, and hUpf3 (Tange et al.
2004 and references therein). Although there are some
indications of a stepwise association of EJC components
with the pre-mRNA (Reichert et al. 2002; Kataoka and
Dreyfuss 2003), the manner in which these proteins are
recruited during splicing remains unclear.
After its stable formation on the mRNA, the EJC under-
goes extensive remodeling within the cell. Some EJC proteins,
such as UAP56, TAP/NXF1, Acinus, and Pinin, are found
solely in the nucleus (Li et al. 2003), dissociating prior
to/during export of the mRNP from the nucleus, whereas
others appear to associate exclusively in the cytoplasm (e.g.,
Upf1) (Applequist et al. 1997). During the first round of trans-
lation, EJCs are removed from the mRNA by the ribosome
and most of the remaining components shuttle back to the
cell nucleus (Dostie and Dreyfuss 2002). Interestingly, the
association of other known components of mRNPs is also
dynamic in nature. Although some proteins remain stably
bound to the mRNA after its export into the cytoplasm, other
factors are removed during or shortly after the passage of the
mRNA through the nuclear pore. For example, CBP80 and
CBP20 (cap binding protein) that form the m7G cap-binding
complex (CBC), and the poly-A-binding protein 2 (PABP2)
are replaced shortly after the emergence of the mRNP in the
cytoplasm, by eIF4E and PABP1, respectively.
EJC-associated proteins play important roles in several
steps of mRNA metabolism. For example, SRm160, RNPS1,
and Pinin have been shown to act as splicing coactivators
or alternative splicing factors (Mayeda et al. 1999; Wang
et al. 2002). UAP56, Aly/REF, and NXF1/TAP are docu-
mented mRNA export factors, where UAP56 is thought to
recruit Aly/REF to the mRNA which in turn recruits NXF1/
TAP, a factor directly interacting with proteins of the
nuclear pore complex (Luo et al. 2001). ‘‘Quality control’’
of spliced mRNAs is achieved in the cytoplasm by a process
termed nonsense-mediated decay (NMD), which removes
mRNAs with premature stop codons (PTCs) from the
mRNA pool. Distinct functions in this process have been
ascribed to the NMD factors hUpf1, hUpf2, and hUpf3, as
well as to the EJC proteins Y14, eIF4A3, andMLN51 in hUpf2-
dependent NMD, and to RNPS1 in hUpf2-independent
NMD (Gehring et al. 2005). In Drosophila, homologs of
Y14 and Magoh play a crucial role in the proper cytoplas-
mic localization of oskar mRNA in developing oocytes
(Hachet and Ephrussi 2001). Finally, EJC formation
increases mRNA translational yield, apparently by enhanc-
ing incorporation of spliced mRNPs into polysomes
(Wiegand et al. 2003; Nott et al. 2004).
Recent, co-immunoprecipitation experiments with HeLa
nuclear extracts revealed that components of the so-called
THO/TREX (transcription- and export-related) complex not
only associate with spliceosomes (Zhou et al. 2002), but also
preferentially with spliced mRNAs as opposed to unspliced
mRNAs (Masuda et al. 2005). In humans, the TREX
complex is comprised of the EJC-associated proteins Aly/
REF and UAP56 together with the THO proteins THOC1
(hHpr1/p84), THOC2 (hRlr1), THOC3 (hTex1), THOC5
(fSAP79), THOC6 (fSAP35), and THOC7 (fSAP24)
(Masuda et al. 2005). Although much evidence indicates
that the function of the TREX complex as an adaptor
between the mRNA and components of the export machin-
ery is conserved among eukaryotes, in Drosophila the
majority of mRNAs can be exported from the nucleus
independently of the THO complex (Rehwinkel et al. 2004).
Here we have isolated, spliced AdML and b-globin
mRNPs under physiological conditions from HeLa nuclear
extract. Analyses of their protein composition by MS
techniques and also by Western blotting led to the identi-
fication of z45 proteins, including several shown for the
first time to be mRNP-associated. Requirements for the
association of these newly detected proteins with mRNA,
including their dependency on splicing, EJC formation, and
the presence of the cap binding complex (CBC) were
subsequently analyzed. Likewise, 59 exon and CBC require-
ments for the initial association of EJC components with
the spliceosome, as well as stable EJC formation on spliced
mRNAs, were also investigated. These studies reveal for the
first time the composition of newly spliced mRNPs isolated
under native conditions and enhance our understanding of
those factors contributing to the recruitment of mRNP-
associated proteins in the nucleus.
RESULTS
MS2 affinity selection of mRNPs spliced in vitro
To determine the protein composition of mRNPs isolated
under native, low-stringency conditions (i.e., in the absence
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of heparin), we adopted the MBP-MS2 purification system
previously used to isolate spliceosomal complexes (Jurica
et al. 2002; Zhou et al. 2002; Deckert et al. 2006). For this
purpose, three repeats of an RNA hairpin bound by the
MS2 coat protein were introduced at the 39 end of an
adenovirus-derived pre-mRNA (AdML-M3) or the human
b-globin pre-mRNA (b-Glo-M3). AdML-M3 lacking an
intron (AdMLDI-M3), which generates nonspliced mRNP,
or AdML-M3 containing a truncated, 15-nt long exon 1
(AdML15-M3), which does not support EJC formation,
were also constructed.
Prior to incubating under splicing conditions, m7G-
capped, 32P-labeled pre-mRNA or mRNA from the intron-
less construct was incubated with an MBP-MS2 fusion
protein. Splicing was carried out for 75 min, and the
amount of unspliced or partially spliced pre-mRNA was
reduced by targeted RNase H digestion of intron sequences.
Glycerol gradient centrifugation was then performed to
separate mRNPs from other RNP complexes. As shown in
Figure 1 for b-globin-M3 pre-mRNA, the distribution of
radioactivity across the gradient revealed the presence of
only one peak in the 30S region, which corresponded to the
spliced b-globin-M3 mRNP. Native full-length AdML-M3
mRNPs also sedimented in the 30S region of the gradient
(data not shown), whereas both spliced AdML15-M3 and
unspliced AdMLDI-M3 mRNPs sedimented in the 20S–25S
region (data not shown). Gradient fractions containing
mRNPs were pooled and affinity selection with amylose
beads was performed. Bound RNP complexes were eluted
under native conditions with an excess of maltose.
RNA was recovered from the eluate, analyzed by de-
naturing PAGE and visualized by silver staining or with
a PhosphorImager. Apart from spliced mRNA, only faint
amounts (<4%) of unspliced pre-mRNA, but no splicing
intermediates could be detected in the b-globin-M3 and
AdML-M3 eluates (Figs. 1, lane 18 and 2A, lane 1), indicat-
ing that these mRNP preparations are essentially free from
spliceosomes or excised intron-containing complexes (Fig. 1,
lower panel). Consistent with these results, silver staining
confirmed the presence of a single major band correspond-
ing either to the b-globin-M3 (Fig. 1, lane 18, upper panel)
or AdML-M3 mRNA (Fig. 2A, lane 2), with only low
amounts of the spliceosomal snRNAs detectable in each case.
Mass spectrometry of spliced, wild-type AdML-M3
and b-Globin mRNPs
Proteins were recovered from the AdML-M3 eluate, frac-
tionated by SDS-PAGE and analyzed by LC-MS/MS mass
spectrometry (Fig. 2B, lane 3; Table 1). A total of z45
proteins were identified. As expected, most EJC-associated
proteins (Y14, Magoh, eIF4A3, RNPS1, Acinus, Pinin,
UAP56, and Aly/REF), with the highly notable exception
of MLN51, were detected. UAP56 and Aly/REF are also
components of the human THO/TREX complex. Consis-
tent with recent reports (Masuda et al. 2005), the TREX-
associated proteins THOC1, THOC2, THOC3, THOC5,
and THOC7 were also found. Numerous SR proteins, as
well as several members of the hnRNP protein family, were
identified; likewise, the general RNA-binding proteins
NFAR-1 (nuclear factor associated with ds-RNA, also
termed ILF3), its binding partner NF45/ILF2 and YB-1,
which were found in all mRNP preparations isolated in the
absence of heparin (Table 1), the cap binding proteins
CBP80 and CBP20, and ARS2 (Arsenite resistance protein
2), a previously identified mRNP protein, were found. MS
analyses of spliced AdML mRNPs also revealed the pres-
ence of proteins with no known connection to spliced
mRNPs: namely BCLAF1 (Bcl-2-associated transcription
factor), ELG, hNHN1 (LOC124245), and TRAP150 (or
Thrap3 for thyroid hormone receptor associated protein 3),
as well as the DEAD-box proteins DDX3, DDX5/p68, and
DDX9 (RNA helicase A), which henceforth will be desig-
nated ‘‘newly identified mRNP proteins.’’
FIGURE 1. MS2 affinity selection of in vitro spliced mRNPs. MS2-
tagged b-globin pre-mRNA was incubated under splicing conditions
in HeLa nuclear extract for 0–75 min (lanes 1–3). After 75 min, intron
containing RNA species were removed by RNAse H digestion (lane 4)
and the splicing reaction was separated on a linear 10%–30% glycerol
gradient (lanes 5–16). Fractions 11–13 were pooled and subjected to
MS2 affinity selection (lane 17, where ‘‘IN’’ represents 10% of the
input material). Bound complexes were eluted with maltose (lane 18,
where 10% of eluted material was analyzed). RNA was recovered,
separated by 12% denaturing PAGE, and visualized by silver staining
(upper panel) or, to detect 32P-labeled species, by PhosphorImager
analysis (lower panel). The positions of snRNA and/or the pre-mRNA
and splicing intermediates and products is shown on the right.
Asterisks mark cleavage products generated by RNase H digestion.
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A number of snRNP proteins were also identified in the
AdML-M3 mRNP eluate, but several lines of evidence
indicate that they do not represent bona fide mRNP
proteins. First, several snRNP proteins, including U5–220K,
U5–200K, U5–100K, SF3b130, and SF3b49 were detected in
a mock affinity selection performed with AdML-M3
pre-mRNA lacking the MS2 tag (Table 1). Finally, immu-
noprecipitation experiments with antibodies against the U4/
U6–61K protein (hPrp31) provided evidence that it does not
associate with purified AdML-M3 mRNPs (Supplemental
Fig. S-1; http://edoc.mpg.de/288481/fulltext/30456/0).
MS analyses of b-globin-derived spliced mRNPs revealed
a very similar protein composition (Table 1). Significantly,
DDX3 and DDX5, as well as the newly identified proteins
BCLAF1, ELG, hNHN1, and TRAP150, were also detected,
indicating that they are common components of all spliced
mRNPs. In contrast, several AdML mRNP proteins (e.g.,
DDX9, THOC1, THOC3, THOC5, and THOC7) were not
detected in the b-globin mRNP, suggesting they may
associate with only a subset of mRNP species, or are loosely
associated components that are readily lost and thus not
consistently observed.
Surprisingly, MLN51, a core component of EJC com-
plexes (Ballut et al. 2005; Tange et al. 2005), was not
detected in either of our purified mRNPs. To determine
whether it may have eluded detection by MS, we performed
Western blotting. MLN51 was detected in HeLa nuclear
extract, but not in purified AdML-M3 mRNPs (Fig. 3A). In
contrast, Magoh, Aly/REF, and CBP80 were readily detected
in both nuclear extract and purified mRNPs (Fig. 3A, cf.
lanes 1,2). To test whether MLN51 is associated with
partially purified mRNPs, we fractionated in vitro splicing
reactions containing AdML-M3 mRNPs on glycerol gra-
dients and analyzed the distribution of MLN51 via Western
blotting. Significantly, gradient fractions enriched in mRNPs
(i.e., 13–17), did not contain detectable levels of MLN51,
whereas CBP80, Aly/REF, and Magoh were clearly present
(Fig. 3B). Taken together, these results confirm that our
MS2 affinity-purified, in vitro spliced mRNPs lack MLN51.
Protein composition of heparin-treated,
spliced mRNPs
To investigate which proteins are stably associated with the
spliced mRNA, we affinity-purified AdML mRNPs as de-
scribed above, except that heparin (which dissociates
loosely associated proteins) was added during the last
5 min of the RNase H digestion. Heparin treatment led
to a shift in the mRNP peak from the 30S to 25S region of
the glycerol gradient, indicating that some protein factors
had indeed dissociated (data not shown). MS analyses of
this ‘‘core-mRNP’’ (Table 1) revealed that significantly
fewer proteins bind mRNA in this complex than in mRNPs
isolated in the absence of heparin. Several, but not all, of
the SR and hnRNP proteins detected in the native mRNPs,
as well as all THO proteins and the general RNA-binding
proteins NFAR1, NF45, and YB-1, were no longer detected.
Likewise, snRNP-associated proteins were no longer found.
A subset of the EJC proteins (i.e., RNPS1 and Pinin) were
also lost; UAP56 was not detected in the core AdML-M3
mRNP, but found in heparin-treated b-globin mRNPs
(Table 1). The association of the remaining EJC proteins
(Y14, Magoh, Aly/REF, Acinus, and eIF4A3) and the CBC
proteins was heparin-resistant. Similarily, while the DEAD-
box helicases DDX5 and DDX9 were lost, DDX3 was still
present. Finally, with the exception of TRAP150, the novel
mRNP proteins BCLAF1, ELG, and hNHN1 remained
associated with the mRNA in the presence of heparin,
indicating that they are stably associated.
Identification of proteins binding unspliced
AdML mRNA
To distinguish between proteins that are deposited on
mRNAs solely as a consequence of splicing, versus those
that can bind in a splicing-independent manner, we
affinity-selected unspliced mRNPs generated after incubat-
ing m7G-capped, intronless AdML RNA (AdMLDI-M3)
under splicing conditions. Essentially only AdMLDI-M3
mRNA was detected in the eluate by PhosphorImager
FIGURE 2. Characterization of affinity-selected AdML mRNPs. RNA
(A) and protein (B) composition of MS2 affinity-purified AdML-M3
mRNPs. (A) RNA from 10% of the MS2 eluate was analyzed as in
Figure 1. (B) Proteins from the entire eluate were separated by SDS-
PAGE and stained with silver. A subset of proteins identified by MS
are indicated at the right (alternative names in parentheses). Lane 1:
molecular weight markers. Lane 2: control pulldown performed with
untagged AdML pre-mRNA in the presence of MBP-MS2.
Protein composition of mRNPs spliced in vitro
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Y14 19.9 gi|4826972 2 3 4 4
Magoh 17.2 gi|4505087 2 2 3 5
eIF4A3 46.9 gi|7661920 10 15 7 15
RNPS1 34.2 gi|6857826 2 1
Acinus 151.8 gi|7662238 7 2 8 8
Pinin 81.6 gi|33356174 6 10
UAP56 49.1 gi|21040371 2 6 6 1
Aly/BEF (THOC4) 26.9 gi|55770864 3 2 5 5 2
THOC1 75.6 gi|4826882 3 1
THOC2 169.6 gi|52486999 1 1
THOC3 38.8 gi|14150171 1
fSAP79 (THOC5) 78.5 gi|50959115 3
fSAP24 (THOC7) 23.7 gi|13376623 1
Cap-binding complex (CBC)
CBP80 91.8 gi|4505343 4 9 8 12 10 6
CBP20 18 gi|19923387 1 3 5 2 4 2
hnRNP- and RNA-binding proteins
NFAR 95.4 gi|24234753 5 1 7 8
NF45 43 gi|24234747 3 1 1 5
YB-1 35.9 gi|34098946 1 6 5 6
ARS2 100 gi|58331218 12 2 12 16 5 9
hnRNP A0 30.9 gi|1911429 1 1
hnRNP A1 38.7 gi|4504445 6 2 6 8 1
hnRNP A2/B1 37.4 gi|14043072 3 5 1
hnRNP C 33.3 gi|14110428 6 6 2 1
hnRNP G 42.1 gi|15277908 3 3 2 1 1
hnRNP L 64.1 gi|52632383 4 4 3
hnRNP R 70.9 gi|5031755 3 3 9
hnRNP U 90.6 gi|74136883 2 1 3 5
hnRNP Q 69.6 gi|23397427 1 2 2
Hsp70 70.9 gi|59960611 3
Hsp84 83.3 gi|123681 2
SR- and SR-related proteins
ASF/SF2 27.8 gi|5902076 3 1 6 3 5
SRp20 19.4 gi|4506901 1 1 5 5 3
9G8 27.4 gi|72534660 4 2 5 5
SRp30-c 25.5 gi|4506903 4 5 2
SRp40 31.3 gi|3929378 1 2
SRp55 39.6 gi|20127499 2 2 7
hTra2a 32.3 gi|37674216 3
hTra2b 33.7 gi|4759098 3 6 12 7
SRm300 300.0 gi|19923466 6
DEAD-box helicases
DDX3 73.3 gi|87196351 2 2 6 7
DDX5 69.2 gi|4758138 1 1 3 6
DDX9 142 gi|4503297 2 4 6
DDX19-like 54.4 gi|13477371 5 5
Newly identified proteins
BCLAF1 106 gi|7661958 2 1 2 9 3 1
ELG 38.9 gi|8923771 3 5 3 6 4
hNHN1 104 gi|31377595 4 3 3 3 2
TRAP150 108.6 gi|4530441 5 1 6 4
Co-purifying proteins
U5–220K (hPrp8) 273.7 gi|3661610 12 8 1 2 2
U5–200K 244.5 gi|45861372 3 7 2 1
U5–116K 109.4 gi|41152056 2 7 3
U5–102K 106.9 gi|40807485 1 2
(continued)
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analysis or silver staining (Supplemental Fig. S-2; http://
edoc.mpg.de/288481/fulltext/30456/0), indicating that highly
pure mRNPs had been isolated. A comparison of the
protein contents of spliced and unspliced AdML mRNPs
revealed that the majority of the mRNP proteins identified
above (i.e., excluding known general RNA binding pro-
teins) associate with mRNAs as a consequence of splicing.
As expected, the unspliced mRNA did not acquire any
members of the canonical EJC (Table 1). The absence of
EJC proteins was also confirmed by Western blot analysis
with antibodies against RNPS1, Y14, and Magoh (Fig. 4,
lane 2). Interestingly, the DEAD-box helicases DDX3 and
DDX5, a subset of the THO proteins and the novel proteins
ELG and hNHN1, were also not detected, suggesting that
their association with mRNPs is dependent on splicing. In
contrast, three other TREX proteins (UAP56, Aly/REF, and
THOC1) were detected in unspliced AdM3DI mRNPs by
MS (Table 1) and by Western blotting (Fig. 4, lane 2). Of
the newly identified mRNP proteins, BCLAF1 and
TRAP150 were also detected, indicating that their associ-
ation with mRNA can occur independent of splicing.
Protein composition of spliced mRNPs lacking an EJC
Unspliced mRNPs lacked not only EJC components but
also a number of additional proteins, suggesting that EJC
formation is required for the association of the latter with
the mRNA. To determine which proteins associate with
spliced mRNPs independently of the EJC, we affinity-
selected mRNPs generated from the AdML15-M3
pre-mRNA, which contains a truncated, 15-nt long exon
1. This pre-mRNA undergoes splicing, but the mRNA
product is defective in EJC assembly due to the lack of an
EJC-binding platform 20–24 nts upstream of its exon–exon
boundary (Le Hir et al. 2001). Analysis of the RNA
composition of the affinity-selected AdML15-M3 mRNPs
(Supplemental Fig. S-3; http://edoc.mpg.de/288481/fulltext/
30456/0) indicated that they were purified to near homoge-
neity. MS (Table 1) and Western blotting (Fig. 4, lane 3)
confirmed that EJC proteins were not present in purified
AdML15-M3 mRNPs. Intriguingly, we also did not find any
TREX proteins, including those that had been previously
detected in both spliced and unspliced mRNPs (Table 1 and
Fig. 4, cf. lanes 2,4,5). Moreover, DDX5 and DDX3 were also
not detected, suggesting that they, together with the TREX
proteins, associate with the mRNA via the EJC. In contrast,
all of the novel mRNP proteins, including those whose
association is dependent on splicing (i.e., ELG, hNHN1),
were detected in AdML15-M3 mRNPs; thus, their associa-
tion with mRNA does not require EJC formation.
RNA sequence requirements for recruitment of EJC
proteins to the spliceosome
Most EJC proteins appear to be recruited to the pre-mRNA



















U5–100K 95.6 gi|41327771 2 2 1
U5–40K 39.3 gi|4758560 2
U4/U6–61K (hPrp31) 55.4 gi|40254869 4
U4/U6–60K 58.4 gi|45861374 2 2
U4/U6–90K 77.4 gi|2853287 2
SF3a120 88.9 gi|5032087 2 2
SF3b155 145.8 gi|54112117 2 2 3
SF3b130 135.5 gi|54112121 1 1 3 2
U1–70K 51.6 gi|29568103 1 2
Sm-D2 13.5 gi|29294624 3 1
Sm-D3 13.9 gi|4759160 1 2
U2AF35 27.9 gi|5803207 1
eIF2C 97.1 gi|6912352 2 1 1
eIF3p40 40 gi|3986482 2 1
KIAA1754 62 gi|12698053 1 3
DEC1 45.4 gi|4503299 5
TFIIIB subunit 5 59.5 gi|6912402 4
Spliced mRNPs were generated after splicing of an adenovirus-derived pre-mRNA (AdML-M3), the human b-globin pre-mRNA (b-Glo-M3),
or AdML-M3 containing a truncated, 15-nt-long exon 1 (AdML15-M3), whereas unspliced mRNPs were generated after incubating
intronless AdML RNA (AdMLDI-M3) under splicing conditions. mRNPs were affinity-selected in the absence (native) or presence of heparin
and their proteins identified by LC-MSMS mass spectrometry after SDS-PAGE. As a control for background binding, an affinity selection was
performed with AdML pre-mRNA lacking an MS2 tag (AdML). The presence of a given protein is indicated by the number of unique peptides
sequenced for that protein. Calculated molecular masses and accession numbers in the GenBank database at the NCBI are indicated.
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of the C complex (Jurica et al. 2002; Reichert et al. 2002;
Deckert et al. 2006). Although stable deposition of the EJC
on spliced mRNA requires the presence of >17 nt upstream
of the exon/exon junction (Le Hir et al. 2001), it is
presently not known whether this EJC-binding platform
is required for the recruitment of EJC proteins to the
spliceosome. We thus affinity-purified a mixture of B*/C
spliceosomal complexes formed on wild-type or truncated
exon 1 MINX pre-mRNA containing an intronic MS2-tag
and a 39 splice site mutation (AG/GG) that abolishes the
second step of splicing. Analysis of the RNA content of
purified complexes revealed that they contained both
unspliced pre-mRNA and splicing intermediates, but no
mRNA (Fig. 5A, lanes 1–4). Quantification of the radioac-
tively labeled RNA species showed that in both cases z85%
of the pre-mRNA had undergone the first step of splicing
and thus was present in the form of C complexes. Purified
spliceosomes contained only small amounts of the U1 and
U4 snRNAs (Fig. 5A), further indicating that predomi-
nantly a mixture of C and catalytically activated B*
complexes had been isolated in both cases. As evidenced
by Western blot analyses, the EJC proteins Y14, Magoh,
RNPS1, Aly/REF, and UAP56 were present in purified B*/C
spliceosomes, regardless of whether an EJC-assembly plat-
form in the –20/24 region of exon 1 was present or not (Fig.
5B, lanes 1,2). In contrast, consistent with results shown
above, spliced mRNPs containing a truncated exon 1, did
not retain these EJC-associated proteins (Fig. 5B, lane 4).
These data suggest that the recruitment of at least a subset
of EJC proteins to spliceosomes does not require an EJC-
assembly platform on the pre-mRNA. Thus, their absence
from purified mRNPs with a truncated 59 exon does not
appear to be due to inhibition of their initial recruitment to
the pre-mRNA, but rather likely the result of impaired EJC
assembly at the time of mRNA formation (see Discussion).
The cap-binding complex is not required for EJC
formation in vitro
A common structural feature of all RNAPII transcripts is
their m7G-cap structure and the cap-binding protein dimer
CBP80/20. The latter aids in the recruitment of various
factors during pre-mRNA processing (see Discussion). We
next analyzed the role of the CBC in the recruitment of EJC
proteins to mRNAs. To prevent CBP80/20 association, we
supplemented in vitro splicing reactions with the cap
analog m7GpppG, and affinity-selected spliced AdML-M3
mRNPs from these reactions after incubating under splic-
ing conditions. Addition of m7GpppG had no effect on
spliceosome assembly (Fig. 6A) nor on the efficiency of
splicing (Fig. 6B) of m7G-capped AdML-M3 pre-mRNA.
Western analyses of wild-type AdML-M3 mRNPs or
mRNPs isolated in the presence of m7GpppG (designated
AdMLDCBC) demonstrated that the latter were devoid of
CBP80 (Fig. 4, cf. lanes 4,5), confirming that the addition
of cap analog effectively inhibits CBC formation. Signifi-
cantly, the EJC and/or TREX-associated proteins RNPS1,
Y14, Magoh, Aly/REF, UAP56/DDX39, and THOC1, as
well as DDX3, were detected both in wild-type, spliced
mRNPs and in those lacking the CBC (Fig. 4, lanes 4,5). In
contrast, none of these proteins were precipitated when
a control affinity-selection was performed with free MS2-
MBP fusion protein (Fig. 4, lane 1). To rule out that CBP80
associates prior to mRNP formation but is subsequently
lost, we isolated A, B, and B*/C spliceosomal complexes
FIGURE 3. MLN51 is not associated with purified, spliced mRNPs.
(A) Western blot of proteins recovered from HeLa nuclear extract
(lane 1) or MS2-affinity selected AdML-M3 mRNPs (lane 2). Proteins
were separated on a 12% polyacrylamide-SDS gel, transferred to
nitrocellulose and visualized by staining with antibodies against
CBP80, MLN51, Aly/REF, and Magoh as indicated. (B) MLN51 does
not co-sediment with partially purified mRNPs. Splicing reactions
containing AdML-M3 mRNPs were fractionated on a glycerol gradi-
ent. RNA and proteins were recovered and analyzed by denaturing
PAGE or SDS-PAGE as described in Figures 1 and 2. 32P-labeled
mRNA was detected by autoradiography (upper panel) and the
distribution of MLN51, CBP80, Aly/REF, and Magoh across the
gradient (lower panels) was determined by Western blot as described
in (A).
FIGURE 4. Western analyses of the protein composition of purified
mRNPs. mRNPs generated from intronless control mRNA (AdMLDI-
M3, lane 2) and pre-mRNAs with a truncated 59 exon (AdML15-M3,
lane 3) or wild-type 59 exon (AdML-M3, lane 4) were purified under
standard conditions, or after addition of m7GppG to the splicing
reaction (AdML-M3DCBC, lane 5). A mock selection was performed
with MBP-MS2 fusion protein (lane 1). Westerns were performed
with z200 fmol of each mRNP (according to cpm of RNA) and the
indicated antibodies as described in Figure 3.
Merz et al.
122 RNA, Vol. 13, No. 1
JOBNAME: RNA 13#1 2007 PAGE: 7 OUTPUT: Wednesday December 6 23:44:19 2006
csh/RNA/127813/rna3368
formed in the presence of cap analog; in no case was CBP80
detectable by Western blotting (data not shown). Finally,
we assayed for EJC assembly on the AdML and
AdMLDCBC mRNAs by performing RNase H digestions
with DNA oligonucleotides complementary to the EJC-
assembly platform and sequences immediately up- and
downstream of it (Fig. 6C). Significantly, the –20/24 region
of both spliced mRNAs was resistant to oligonucleotide-
directed RNase H cleavage, while the flanking sequences
were efficiently cleaved. Taken together, these results in-
dicate that the recruitment of EJC proteins to the pre-
mRNA and the subsequent assembly of a stable EJC at the
–20/24 region of a spliced mRNA does not require the
presence of the CBC.
Several newly identified mRNP proteins require the
CBC for mRNA association
The newly identified mRNP proteins BCLAF1, ELG,
hNHN1, and TRAP150, and also the previously identified
ARS2, were detected in spliced mRNPs lacking an EJC.
Moreover, with the exception of TRAP150, they were
insensitive toward heparin treatment, indicating their tight
association with the mRNP. Targeted RNAse H digestion
indicated that regions of the mRNA flanking the –20/24
position are not bound by protein, suggesting that the
aforementioned proteins might associate with other regions
of the mRNA or via the CBC. To test the latter possibility,
CBC-bound and DCBC AdML mRNPs were purified and, as
antibodies against the newly identified proteins were not
available, mRNPs were analyzed for the
presence of these proteins by MS. In this
instance, mRNPs were first digested with
RNAses A/T1, and proteins were sub-
sequently digested in-solution with tryp-
sin (i.e., without prior SDS-PAGE
fractionation as above) prior to LC-
MS/MS mass spectrometry. The protein
composition of the wild-type mRNPs
determined via this MS method was very
similar to that described above (Table 2;
data not shown). Although the previ-
ously undetected EJC protein SAP18
could now be found, MLN51 remained
undetectable. Consistent with our initial
observations, ARS2, BCLAF1, ELG,
hNHN1, and TRAP150 were detected
in spliced AdML-M3 mRNPs containing
the CBC (Table 2). In contrast, only
TRAP150 was detected in spliced
AdMLDCBC mRNPs, indicating that
the association of ARS2, BCLAF1, ELG,
and hNHN1 is mediated, at least in part,
by the CBC.
DISCUSSION
We have succeeded in purifying under native conditions
a series of spliced and unspliced mRNPs from HeLa nuclear
extract, and determining their protein composition by MS.
These studies identified a number of proteins previously
not known to be mRNP-associated. A comparison of the
protein composition of wild-type mRNPs with those of
unspliced mRNPs and spliced mRNPs lacking an EJC
revealed that the association of several mRNP-associated
proteins, while dependent on splicing, does not require
formation of the EJC. Characterization of spliceosomal B*/C
complexes formed on a pre-mRNA containing a truncated
59 exon demonstrated that the EJC binding platform at the
–20/24 region of the 59 exon is not required for the initial
recruitment of EJC proteins during splicing. Finally, we
demonstrate a differential requirement of the CBC for the
recruitment of EJC proteins versus several of the newly
identified mRNP proteins.
Proteins associated with native affinity-purified,
spliced mRNPs
Our affinity-purified mRNPs were essentially free of splice-
osomes, as judged by the fact that (1) only faint amounts of
unspliced pre-mRNA but no splicing intermediates were
detected and (2) MS did not uncover splicing factors acting
during activation, catalysis, or spliceosome disassembly
(e.g., hPrp16, hSlu7, or hPrp43). However, trace amounts
FIGURE 5. EJC proteins associate with spliceosomal C complexes formed on pre-mRNA with
a truncated 59 exon. (A) RNA content of MS2 affinity-purified B*/C spliceosomes.
Spliceosomes were allowed to form on wild-type MINX pre-mRNA (E1-WT, lanes 1 and 2)
or MINX pre-mRNA with a truncated 15 nt long 59 exon (E1–15, lanes 3 and 4). After affinity
purification of B*/C complexes, RNA was recovered and visualized by PhosphorImager
analysis (lanes 1 and 3) and silver staining (lanes 2 and 4). Pre-mRNA and splicing
intermediates are indicated on the right, and products of RNase H digestion are marked with
asterisks. (B) Western analyses (see Figure 3) were performed with purified B*/C complexes or
mRNPs with a wild-type or truncated 59 exon (as indicated above each lane) and those
antibodies indicated at the right. CBP80 is a loading control.
Protein composition of mRNPs spliced in vitro
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of spliceosomal snRNAs were detected by silver staining,
and a number of snRNP-associated proteins were identified
by MS. That the identified snRNPs are merely contami-
nants and do not represent mRNPs complexed with
snRNPs (i.e., mRNPs not completely released from post-
spliceosomal snRNP-containing complexes) is supported by
the fact that (1) mRNPs complexed with one or more
snRNPs would be expected to sediment with a higher S
value, and (2) several proteins identified have never been
detected in late spliceosomal complexes (e.g., U1–70K or
U4/U6-associated proteins), whereas
snRNP proteins specifically associated
with the 35S form of the U5 snRNP
(i.e., Prp19 and associated proteins),
which is formed late in the splicing
pathway, were not found. Although
the association of one or more individ-
ual snRNP proteins with the mRNP
cannot be rigorously excluded, they do
not appear to be bona fide mRNP
proteins. First, several snRNP-associ-
ated proteins (but none of the EJC,
TREX, or newly identified mRNP pro-
teins) were also eluted from an amylose
matrix in control pulldowns with non-
tagged AdML pre-mRNA, indicating
that they bind nonspecifically. Second,
the number of unique peptides identi-
fied for many of these proteins by MS is
relatively low (especially if one takes
their size into account). Finally, immu-
noprecipitation experiments indicated
that the U4/U6–61K protein is not
associated with mRNPs.
As expected, affinity-purified, spliced
AdML and b-globin mRNPs contained
most components known to associate
with the EJC in the nucleus. Consistent
with previous reports (Le Hir et al. 2001),
their association was dependent on splic-
ing (i.e., they were not found in
AdMLDI-M3 mRNPs) and also on the
presence of a binding platform in the
–20/24 region of the 59 exon (i.e., they
were absent from AdML15-M3 mRNPs).
Several, loosely associated EJC proteins
such as SRm160, TAP/NXF1, and Upf3a/b,
were not detected, suggesting they were
lost during purification. More surpris-
ingly, we did not detect the EJC core
component MLN51 either by different
MS methods or by Western blotting in
any of our purifed mRNPs. Interestingly,
MLN51 was previously not detected by
MS in AdML mRNPs affinity-purified in
the presence of heparin (Tange et al. 2005); however, in
contrast to our studies, subsequent Western blotting experi-
ments confirmed its presence. Furthermore, it was detected
by MS in double-affinity-purified EJC complexes subse-
quently purifed from the above-mentioned mRNPs (Tange
et al. 2005). Whether the inability to detect MLN51 in our
purified mRNPs is merely a detection problem, or reflects its
true absence, is presently unclear. In vitro reconstitution
experiments revealed that the association of Magoh, Y14,
and eIF4A3 with mRNA is not strictly dependent upon the
FIGURE 6. The CBC is dispensable for EJC formation in vitro. An excess of m7GpppG does
not affect (A) splicing complex formation nor (B) splicing. Splicing was performed with
AdML-M3 pre-mRNA 6m7GpppG (as indicated) for the indicated times. Splicing complex
formation or splicing was analyzed on an agarose gel or by denaturing PAGE, respectively,
followed by PhosphorImager analysis. The positions of the various spliceosomal complexes (A)
or pre-mRNA/intermediates/products (B) are indicated at the right. (C) The absence of the
CBC does not inhibit stable EJC formation. EJC formation at the 20/24 region was analyzed
by RNase H digestion of the 59 exon after allowing for the formation of spliced mRNP in the
absence (lanes 1–5) or presence (lanes 6–10) of m7GpppG. 40, 22, and 8 indicate the
central nucleotide of the complementary DNA oligo used, relative to the exon–exon junction.
Arrows on the right mark actual/expected positions of RNase H cleavage products. RNAs were
analyzed by denaturing PAGE and visualized with a PhosphorImager.
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presence of MLN51 (Ballut et al. 2005). Thus, although
stable EJCs form on our in vitro spliced mRNPs (Fig. 6C), it
is conceivable that MLN51 might, nonetheless, be absent.
MLN51 is a predominantly cytoplasmic protein, consistent
with the idea that it might be stably incorporated into EJCs
first in the cytoplasm. Although MLN51 was previously
found in purified mRNPs and EJCs generated in nuclear
extract (Tange et al. 2005), these experiments were per-
formed in the presence of an excess of GST-Y14/Magoh,
which may have driven the low amounts of nuclear MLN51
into EJC complexes. Likewise, TAP-tagged MLN51 is found
in EJCs formed after in vitro splicing in Hela nuclear extract,
when the latter is supplemented with an excess of the tagged
protein (Degot et al. 2004; Ballut et al. 2005). Overexpressed
EYFP-tagged MLN51 was recently shown to co-localize with
Magoh in nuclear speckles (Degot et al. 2004); however,
whether endogenous nuclear MLN51 behaves in a similar
manner is not clear.
Recent immunoprecipitation experiments indicated that
components of the human TREX complex are associated
with spliced mRNPs, and also, to a much lesser extent with
unspliced mRNPs (Masuda et al. 2005). Indeed, with the
exception of THOC6, we detected nearly all known
components of the human TREX complex in spliced AdML
mRNPs. Based on the number of unique peptides identified
(and also taking their molecular weight into consideration),
some of the THO proteins identified appear to be un-
derrepresented. Thus, they may be loosely-associated
mRNP components that are readily lost during affinity
selection. Consistent with this idea, only UAP56, Aly/REF
and THOC2 were found in b-globin mRNPs, and only the
association of UAP56 and Aly/REF withstood heparin-
treatment, indicating that they, in contrast to other TREX
proteins, are stably associated. Similarily, aside from Aly/
REF, no TREX-associated proteins were previously found
by MS in heparin-treated, affinity-purified, spliced mRNPs
(Tange et al. 2005). The association of the THO proteins
with purified mRNPs was dependent on both splicing (with
the curious exception of THOC1) and EJC formation
(Table 1; Figure 4), consistent with the idea that the export
factors Aly/REF and/or UAP56—which are also EJC-
associated—or potentially other EJC components, mediate
their association with the mRNA.
Multiple members of the SR and hnRNP protein families
were found in purified mRNPs. Native mRNPs isolated
after in vitro splicing contained both shuttling hnRNP
proteins (A1, A2/B1, K, and L), which accompany the
mRNA to the cytoplasm, and nonshuttling proteins (e.g.,
hnRNP C), which can retain mRNAs in the nucleus. The
latter are typically removed via interactions with matrix-
associated proteins and other cofactors (e.g., the nuclear
pore complex, Lamins, TAP/p15), prior to mRNA export.
SRp20 and 9G8 are shuttling SR-proteins that are not
retained in the nucleus, but rather accompany the mRNP
to the cytoplasm (Huang et al. 2003). In good agreement
with previous studies (Dreyfuss et al. 2002 and references
therein), the shuttling proteins hnRNP A1, A2/B1 and L,
and SRp20 and 9G8 remain stably bound to the mRNA
even in the presence of heparin (Table 1). SRp20 and 9G8
were shown to interact with RNAs independent of splicing
(Cavaloc et al. 1999). However, most SR proteins were
not detected in AdMLDI-M3 mRNPs (with the exception
of SRp20), suggesting that their recruitment is splicing-
dependent.
Identification of novel mRNP-associated proteins
Several proteins previously not known to be mRNP-
associated were detected in purified mRNPs (but not in
mock affinity-selections), including the DEAD-box heli-
cases DDX3, DDX5/p68, and DDX9. DDX3 is a nucleo-
cytoplasmic shuttling protein that was recently implicated
in the nuclear export of unspliced HIV RNAs (Yedavalli
et al. 2004). It is a predominantly cytoplasmic protein, but
can be detected by immunofluorescence in a speckle-like
pattern in HeLa cell nuclei (Owsianka and Patel 1999) and
also has been found in a mixture of affinity-purified human
spliceosomes and mRNPs (Zhou et al. 2002) and spliceo-
somal B complexes (Deckert et al. 2006). DDX3 was also
detected in mRNA transport granules in murine neurons
(Kanai et al. 2004). DDX5/p68 is an essential splicing factor
that facilitates unwinding of the U1 snRNA/59 splice site
base-pairing interaction (Liu 2002). Consistent with its role
in splicing, it has been detected in numerous spliceosomal
complexes, including A, B*, and C (Hartmuth et al. 2002;
Zhou et al. 2002; Deckert et al. 2006). Interestingly, DDX3
is stably associated with mRNPs after heparin treatment,
and DDX3 and DDX5 are exclusively found in spliced
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mRNPs (AdML-M3 or AdMLDI-M3) were purified from standard
splicing reactions (+CBC) or those supplemented with m7 GpppG
(DCBC). mRNPs were digested with RNases A/T1 and trypsin in
solution, and peptides were analysed by LC-MSMS mass spec-
trometry. The presence of a given protein (shown on the left) is
indicated the number of unique peptides sequenced for that
protein. Only a subset of those proteins identified is shown.
Protein composition of mRNPs spliced in vitro
www.rnajournal.org 125
JOBNAME: RNA 13#1 2007 PAGE: 10 OUTPUT: Wednesday December 6 23:44:37 2006
csh/RNA/127813/rna3368
mRNAs carrying an EJC (Table 1), implicating EJC com-
ponents in their association with the mRNA. DDX9 (RNA
helicase A) has also been detected in a mixture of affinity-
purified spliceosomes (Rappsilber et al. 2002; Zhou et al.
2002), but its association with mRNPs is nonetheless not
dependent on splicing nor on the presence of an EJC
(Table 1). It plays a role in CREB-dependent transcription,
but has also been implicated in the nuclear export of unspliced
viral RNAs (Li et al. 1999). Whether it (as well as DDX3)
also contributes to mRNA export is presently not clear.
ELG, hNHN1, BCLAF1, and TRAP150 were also identi-
fied for the first time in affinity-purified, spliced mRNPs.
All of these proteins have no known function in splicing or
mRNA export. Essentially nothing is known about hNHN1
or ELG and with the exception of a CCCH zinc finger in
hNHN1, they do not contain motifs suggestive of a partic-
ular function. Nonetheless, hNHN1 was identified in
affinity-selected pre-catalytic spliceosomal B complexes,
whereas the human ELG protein was first found in C
complexes isolated in the absence of heparin (S. Bessonov,
H. Urlaub, and R. Lu¨hrmann, unpubl.). Thus they associate
during splicing prior to mRNA formation. Interestingly,
the association of ELG and hNHN1 (but not BCLAF1 or
TRAP150) with mRNA was dependent on splicing, but did
not require EJC formation. Rather, as discussed below,
their mRNP association was dependent on the presence of
CBP80/CBP20.
BCLAF1 is a Bcl-2-associated protein and acts as a death-
promoting transcriptional repressor during apoptosis
(Kasof et al. 1999). The thyroid-hormone receptor associ-
ated protein 3 (TRAP150 or Thrap3) has been described as
a member of the multiprotein complex TRAP/Mediator,
involved in transcriptional activation of various genes (for
review, see Malik and Roeder 2000). However, TRAP150
lacks known conserved domains or sequence motifs con-
nected with splicing or transcription. While TRAP150
dissociates from mRNA under stringent conditions—like
general RNA-binding proteins (e.g., YB-1, NFAR1)—B-
CLAF1, ELG, and hNHN1 are stable components of
heparin-treated mRNPs. However, in previous studies
(Tange et al. 2005), they were not detected by MS in
MS2 affinity-purified mRNPs isolated in the presence of
heparin, presumably due to the higher concentration of
heparin used in the latter studies.
An EJC binding platform at position 20/24 of exon 1
is not required for EJC protein recruitment
With the exception of Pinin and Acinus, which are found in
complex A and B, respectively, the canonical EJC proteins
appear to associate with the pre-mRNA first after catalytic
activation of the spliceosome (i.e., in spliceosomal C
complexes) (Jurica et al. 2002; Reichert et al. 2002;
S. Bessonov, H. Urlaub, and R. Lu¨hrmann, unpubl.). By
isolating spliceosomal B*/C complexes assembled on a
pre-mRNA with a truncated 59 exon and analyzing their
composition by Western blotting, we demonstrate that the
EJC proteins Aly/REF, UAP56, Magoh, Y14, and RNPS1 do
not require the EJC binding platform at the –20/24 region
of the 59 exon for their association with the pre-mRNA. As
only a handful of EJC proteins were analyzed, we cannot
rule out that one or more EJC proteins may associate with
spliceosomes in a manner dependent on this region.
Nonetheless, our data indicate that there is a differential
requirement for the 20/24 region for initial recruitment
of EJC proteins and formation of a stable EJC on spliced
mRNA. Interestingly, previous studies revealed that at least
nine proteins contact the 59 exon in a highly dynamic
manner during splicing (Reichert et al. 2002) At the time of
exon ligation, a new set of proteins associates with position
24. Although Aly/REF has been shown to crosslink to the
–20/24 region in the spliceosomal C complex (Reichert
et al. 2002), the absence of this region does not significantly
affect its association with catalytically active spliceosomes
(Fig. 5). Nonetheless, Aly could play a role in providing
positional information for EJC deposition and as nucle-
ation factor for EJC assembly in the –20/24 region. It will be
interesting in the future to determine which spliceosomal
proteins are required for the recruitment of EJC proteins
and whether EJC proteins are recruited as preorganized
subcomplexes.
Influence of the cap binding complex on the
association of proteins with mRNA
The m7G-cap plays an essential role in several steps of RNA
metabolism, including pre-mRNA splicing, 39 end forma-
tion, and RNA transport (for review, see Lewis and
Izaurralde, 1997), as well as translation and NMD (Hosoda
et al. 2005) It is tightly bound by CBP80 and CBP20, which
form the so-called cap binding complex (CBC). The CBC
has been shown to aid in the recruitment of factors during
splicing, including facilitating the interaction of the U1
snRNP with the cap-proximal 59 splice site (Lewis et al.
1996). The CBC also physically interacts with pre-mRNA 39
end processing factors, thereby aiding 39 end formation
(Flaherty et al. 1997). Here we have tested whether the CBC
aids the association of components of the spliced mRNP.
Western blot analysis and targeted RNase H digestion
revealed that an EJC is assembled on both CBC-bound
and DCBC mRNPs (Figs. 4, 6). Thus, EJC formation during
in vitro splicing in HeLa nuclear extracts occurs independent
of the cap binding complex. During the course of this work,
in vitro reconstitution experiments with recombinant
Magoh, Y14, eIF4A3, and MLN51/BTZ revealed that the
stable interaction of these core EJC components with RNA
does not require the presence of an m7G cap, nor CBP80/20
(Ballut et al. 2005). The newly identified proteins ELG,
hNHN1, and BCLAF1, on the other hand, and also ARS2,
were not detected in purified mRNPs lacking a CBC (Table
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2). Whether these proteins directly contact the CBC, or their
association is indirectly stabilized by it, is presently not clear.
MATERIALS AND METHODS
Construction of plasmids and in vitro transcription
of RNAs
pAdML-M3 has been described (Zhou et al. 2002), and intronless
AdMLDI-M3 and AdML15-M3 were generated by PCR-based
techniques. pGlo-M3 was produced by overlap-extension of
a PCR product of the b-globin pre-mRNA. All in vitro tran-
scriptions were performed with T7 RNA polymerase from PCR-
generated DNA templates.
In vitro splicing and MS2 affinity purification
of mRNPs
Recombinant MBP-MS2 fusion protein was purified essentially as
described (Jurica et al. 2002). HeLa nuclear extract was prepared
according to Dignam et al. (1983), except initial cell lysis was
performed in MC buffer (10 mM Hepes, pH 7.6; 10 mM KOAc; 0.5
mM MgOAc; 5 mM DTT; 13 Complete Protease Inhibitor). In
vitro splicing reactions contained 40% HeLa nuclear extract in
Buffer D (20 mM Hepes-KOH, pH 7.9; 10% glycerol; 100 mM KCl;
1.5 mM MgCl2; 0.5 mM DTT), supplemented with 1.5 mM ATP
and 15 mM creatine phosphate. The final concentrations of MgCl2
and KCl were adjusted to 3.5 mM and 80 mM, respectively. For
splicing analysis, RNA was recovered and separated on a 7 M urea-
12% polyacrylamide gel and detected by autoradiography. For
analysis of spliceosome assembly, AdML-M3 pre-mRNA was in-
cubated under splicing conditions for 0–20 min, 2 mL of heparin (4
mg/mL) were added to 10 mL of the splicing reaction and
complexes were analyzed on a 1.5% native agarose gel.
To isolate mRNPs, 15 pmol/mL of pre-mRNA were preincu-
bated with a 30–50-fold molar excess of purified MBP-MS2 fusion
protein for 30 min on ice. After incubation under splicing
conditions for 75 min, three DNA oligonucleotides complemen-
tary to intronic sequences of either the AdML or b-globin pre-
mRNA were added and the reaction mixture was incubated for
20 min at 30°C. In some instances heparin was added (final
concentration 0.25 mg/mL) after 15 min of RNAse H digestion,
and reactions were incubated at 30°C for 5 min. For preparative
isolation of mRNPs, 700 mL of an in vitro splicing reaction were
loaded onto a 4.4 mL linear 10%–30% glycerol gradient contain-
ing 20 mM Hepes-KOH 7.9, 150 mM NaCl, 1.5 mM MgCl2.
Gradients were centrifuged at 55,000 rpm in a Sorvall TH-660
rotor and harvested manually in 175 mL fractions from the top.
RNA and protein were extracted from 100 mL of odd-numbered
fractions and analyzed as described below. Gradient fractions
containing mRNP were pooled and passed twice over a 150 mL
amylose column. After washing with 30 column volumes of
MBP150 buffer (20 mM Hepes-KOH 7.9, 150 mM NaCl, 1.5
mM MgCl2), mRNPs were eluted with MBP150 buffer containing
12 mM maltose. Isolation of DCBC mRNPs was performed as
above after adding 1 mM m7GpppG to the nuclear extract and
preincubating for 10 min on ice. Detection of a stable EJC at
position 20/24 was determined by RNase H digestion as
previously described (Le Hir et al. 2000).
Purification of activated spliceosomal
B*/C complexes
To isolate a mixture of B* and C spliceosomal complexes, splicing
was performed in vitro with MINX pre-mRNA containing two
intronic MS2-RNA aptamers and a 39 splice site mutation (i.e.,
AG/GG) that abolishes the second step of splicing. Pre-mRNAs
containing either a wild-type exon 1 (WT) or a truncated exon 1
(E1–15, 15 nt in length) were incubated under splicing conditions
for 70 min and RNase H digestions were performed with oligos
directed against nt –24 to +6 (WT) or nt –6 to +6 (E1–15) relative
to the 59ss to remove pre-mRNAs not engaged in C complexes
(Jurica et al. 2002). Spliceosomes assembled on both substrates
were purified by MS2 affinity selection as described above.
Antibodies and immunoblotting
Mouse monoclonal anti-MBP antibody was obtained from Biozol.
Rabbit polyclonal peptide antibodies raised against peptides of
U4/U6–61K, CBP80, hSnu23, Aly/REF, and UAP56 were affinity-
purified on a SulfoLink column (Pierce) containing the cognate
peptide. All other antisera were used without prior affinity purifi-
cation. For immunoblotting, proteins extracted from purifed
mRNP complexes were separated on a 12% polyacrylamide gel
and transferred to nitrocellulose. Immunostaining was performed
with an ECL detection kit (Amersham).
Mass spectrometry
MS was performed with SDS-PAGE separated proteins as previously
described (Deckert et al. 2006) or alternatively, mRNPs were digested
in-solution with RNAses A and T1 for 30 min at 37°C, followed by
overnight digestion with trypsin, and peptides were analyzed in an
LC-coupled ESI Q-ToF (Waters) and/or a linear iontrap (4000
QTrap, Applied Biosystems) mass spectrometer under improved
conditions (S. Bessonov, H. Urlaub, and R. Lu¨hrmann, unpublished).
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